SUMMARY When rectal biopsies from 65 patients with ulcerative colitis and 20 patients with Crohn's disease were stained for mucins, an abnormal pattern (excess of sialomucins) was seen in about half of them. This is in contrast with 65 cases of non-specific proctitis where the mucin pattern of rectal biopsies was normal in all except one case. The abnormal mucin secretion in patients with ulcerative colitis was apparently related to the activity, duration, and extent of the disease. All biopsies with dysplasia showed predominant sialomucin staining except one. All biopsies showing sialomucins during remission also had dysplasia, while during active disease a number of biopsies had increased sialomucins without the evidence of dysplasia. It is not known if such cases will subsequently develop morphological atypia.
Alterations in the composition of mucous secretion have been described in the gastrointestinal tract in association with malignancy. 16 In the colon these changes are characterised by an increased proportion of sialomucins in contrast with normal biopsies where sulphomucins predominate. The findings of these abnormal mucin patterns in solitary ulcer syndrome,7 however, raised the question whether such changes were non-specific and simply related to inflammation.
We, therefore, decided to study mucous secretion patterns of other inflammatory bowel diseases. We were particularly interested to see if alteration in mucin composition was related to the histological severity, extent, and duration of the inflammation or the presence of dysplasia and whether such changes can be used to distinguish ulcerative colitis, Crohn's disease, and non-specific proctitis.
Methods

PATIENTS
A total of 240 rectal biopsies were examined from 65 cases of ulcerative colitis, 20 of definite colonic Crohn's disease, and 65 of non-specified proctitis collected over a four-year period . Cases of ulcerative colitis complicated with carcinoma or treated by colectomy and ileorectal anastomosis were excluded, and these will be reported separately.
CRITERIA FOR DIAGNOSIS
Ulcerative colitis Ulcerative colitis was diagnosed by clinical history, involvement of the rectum on sigmoidoscopy, combined with the findings of barium studies and colonoscopy, absence of strictures, fistulae, and small bowel involvement. All patients had a rectal biopsy showing either a diffuse mixed or chronic inflammatory infiltrate in the lamina propria (active or resolving phase), or evidence of past disease with shorter and distorted crypts but little or no inflammation and good preservation of mucous secretion (remission phase). In active disease ulceration and crypt abscesses were common and mucous depletion varied in proportion to the severity of the inflammation.
Crohn's disease Crohn's disease was diagnosed by 'classical' histological changes on rectal biopsy with the presence of non-caseating epitheloid granulomas and barium studies or colonoscopy. All patients had a barium meal and follow through and in some involvement of small bowel was noted. Statistical analysis used the Fisher-exact probability test.
Results
ULCERATIVE COLITIS
The Tables show the mucin changes as normal, mixed pattern or sialomucins in the active, resolving or remission phases of ulcerative colitis. As the mixed mucin pattern and the resolving stage of ulcerative colitis are subjective histological changes susceptible to variations in interpretation, the biopsies showing these changes have been excluded from the statistical analysis. These results, which are included in the Tables, show that the biopsies with resolving colitis produce mucin changes which are intermediate between the biopsies of active disease and those in the stage of remission. A total of 120 rectal biopsies from 65 patients were studied, but it was not possible to accurately assess the extent and duration of disease in five cases.
DISEASE ACTIVITY
Forty-six out of 81 (57%) biopsies during active phase but only five out of 26 (19%) in remission show the presence of sialomucins. In the active phase, the frequency of predominant sialomucins staining seems to be related to the histological severity of the disease, being found in 45% and 61% of the cases with mild and severe inflammation respectively (p=0.01) ( Tables 1 and 2 ).
EXTENT OF DISEASE
In the active phase the presence of sialomucins seems more pronounced in total (69% of biopsies) than left-sided colitis (48% of biopsies), but these differences are not statistically significant. The difference in the remission phase, however, is significant with 27% of biopsies from total colitis showing predominance of sialomucins compared with 12% in left-sided colitis.
DURATION OF DISEASE
This seems to influence mucin change only during remission. None of the biopsies from nine patients who had ulcerative colitis for less than 10 years (Table 4) . As inflammation in this disease is patchy, it is not possible to assess the effects of disease activity on mucin secretion. The extent (colonic or small bowel+colonic) and duration of disease had no effect on mucin secretion patterns. 
NON-SPECIFIC PROCTITIS
Sialomucins were dominant in only one out of 78 rectal biopsies from 65 patients with non-specific proctitis. In this patient mucin composition reverted to normal two years later when he was asymptomatic.
MISCELLANEOUS
All biopsies from a variety of non-inflammatory non-neoplastic colonic diseases revealed a normal mucous pattern.
Discussion
In biopsy material, it is sometimes difficult to distinguish between the various inflammatory bowel diseases. The two main entities, ulcerative colitis and Crohn's disease, present many common features and in the absence of granulomas, which are seen in only 60% of the cases, the distinction between the two in a single rectal biopsy is not always possible.8 15 The histological assessment is subjective and relies on a combination of criteria which are often lost in a superficial rectal biopsy because of the patchy nature of the inflammatory process in Crohn's disease and its transmural involvement. The preservation of mucous secretion in Crohn's disease, even in the presence of marked inflammation, and its depletion in ulcerative colitis, though helpful, is not a reliable criterion as a similar picture is found in the resolving phase of ulcerative colitis. We hoped that this difference in quantitative mucin assessment would also be mirrored by qualitative changes which would be of value in the differential diagnosis of these two conditions. Biopsies taken from patients with Crohn's disease, however, and ulcerative colitis both showed the presence of abnormal mucins in almost the same number of cases. 20 Thus, as it might be expected, our results demonstrate qualitative changes in mucins in both ulcerative colitis and Crohn's disease which may represent increased cell turnover in a mucosa subjected to constant damage. 21 In view of this, the finding of a consistently normal mucin pattern in non-specific proctitis is surprising, and perhaps suggests different cell kinetics resulting from mucosal damage in this condition.
One of the problems in histological interpretation of biopsy material from ulcerative colitis is the assessment of the cancer risk in patients with epithelial dysplasia. Its value is limited by the fact that it is not a constant finding in carcinoma, it may be present without the development of neoplasia and it is a focal condition. It is particularly difficult to decide in the presence of inflammation whether the epithelial atypia is a precarcinomatous change or post-inflammatory.8 10 2 While these problems can be lessened with multiple colonoscopic and rectal biopsies and more careful endoscopic search for suspicious areas of dysplasia, we have previously suggested4 that a study of qualitative differences in mucin secretion might also be helpful in predicting the development of cancer in patients with colitis. Our recent results indicate, however, that sialomucins are intimately related both to dysplasia and the severity of the inflammation. Thus, are sialomucins to be regarded only as a non-specific response to inflammation? In support of this argument is the finding of abnormal mucins in the absence of dysplasia in Crohn's disease and the solitary-ulcer syndrome.7
In favour of a close relationship between the occurrence of dysplasia and abnormal mucins is the presence of normal mucins in non-specific proctitis and in other miscellaneous conditions of large bowel even when inflammation is severe. Further evidence of this relationship is the coexistence of dysplasia and sialomucins in rectal biopsies taken from the patients with ulcerative colitis during the remission phase in the absence of inflammation.
An association between dysplasia and abnormal mucins would be logical, as there is evidence of impaired cell maturation in the dysplastic epithelium with the gradual replacement of the mature cell population of the normal mucosa by intermediate and immature cell types. This might result in incomplete glycoproteins being produced perhaps similar to those synthesised by mitotically active intestinal cells and their counterparts in both neoplasia and fetal gut. 23 In the latter, sialomucins are secreted in the early stages of development with sulphomucins appearing later. 24 There were in this study a group of patients with active disease and sialomucins but no dysplasia. It is possible that such cases indicate the first changes of dysplasia, preceding the morphological atypia, and, in biopsies taken on subsequent occasions, the typical histological features will develop. Alternatively, the mucin changes may represent a non-specific reaction which regresses when the inflammation ceases. The only way to answer this question is to assess mucin changes in rectal biopsies in a group of patients followed-up over several years. This study is now in progress.
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